Niño con síndrome tricorrinofalángico tipo II acompañado de baja estatura / Triehorhinophalangeal syndrome type II presenting with short stature in a child

El síndrome tricorrinofalángico (STRF) tipo II (sinónimo: síndrome de Langer-Giedion) es un síndrome autosómico dominante raro que afecta genes adyacentes y que se produce como resultado de una microdeleción que abarca los genes EXTl y TRPSl en la banda 8q24 (OMIM 150230). En este síndrome se combinan características de dos trastornos autosómicos dominantes: el síndrome tricorrinofalángico tipo I (OMIM 190350) y la osteocondromatosis múltiple hereditaria tipo I (OMIM 133700). El STRF tipo II se caracteriza por escaso cabello, nariz prominente y de extremo bulboso, surco nasolabial plano y alargado, epífisis de las falanges en forma de cono, retraso de la edad ósea durante la infancia y osteocondromas cartilaginosos múltiples. En este artículo presentamos el caso de un paciente de Turquía con las características clínicas y los signos óseos del STRF tipo II en el que se detectó una deleción de 13,8 Mb en las bandas 8q23.1-8q24.13.

Trichorhinophalangeal syndrome type II (TRPSII) (synonym: Langer-Giedon syndrome) is a rare autosomal dominant contiguous gene syndrome, resulting from a microdeletion encompassing the EXT1 and the TRPS1 gene at 8q24 (MIM#150230). This syndrome combines the clinical features of two autosomal dominant disorders, trichorhinophalangeal syndrome type I (MIM#190350) and hereditary multiple osteochondromas type I (MIM # 133700). TRPSII is characterized by sparse scalp hair, a long nose with a bulbous tip, long flat philtrum, cone-shaped epiphyses of the phalanges, retarded bone age in infancy and multiple cartilaginous osteochondromas. We report a Turkish patient who had the clinical features and skeletal signs of TRPSII in whom a 13.8Mb deletion in 8q23.1- 8q24.13 was detected.

La deficiencia de zinc: un problema global que afecta la salud y el desarrollo cognitivo / Zinc deficiency: a global problem that affect the health and cognitive development

La deficiencia de zinc afecta aproximadamente un tercio de la población mundial, principalmente en los países en vía de desarrollo, en las áreas rurales y en las comunidades más pobres, donde constituye un importante factor de riesgo asociado a enfermedad. En este trabajo se realiza una revisión de los avances científicos que han permitido conocer el papel fundamental del zinc en el control de la neurogénesis, el funcionamiento del cerebro y el desarrollo cognitivo. Con el fin de generar en los profesionales de salud, interés por la investigación de los efectos de la deficiencia de zinc en el desarrollo neurológico y cognitivo y su impacto negativo en el desarrollo cultural, social y económico de los pueblos(AU)

The zinc deficiency affects approximately a third of the world population, principally in the developing countries, the rural areas and in the poorest communities, where this micronutrient deficiency is one of the most prevalent risk factor for nutrientrelated diseases. This paper compiles scientific advances about the key role of the essential trace element zinc in the neurogenesis control, brain function and cognitive development. The aim of this work is to generate in health professionals, interest about the zinc deficiency effects in neuro-intellectual development and its negative impact in the cultural, economic and social development of the countries(AU)

Tratamento com hormônio de crescimento em crianças com doenças crônicas: [revisão] / Growth hormone therapy for children with chronic diseases: [review]

Crianças com doenças crônicas freqüentemente apresentam crescimento inadequado e baixa estatura. A falência do crescimento é multifatorial. Nas doenças inflamatórias, como na artrite juvenil idiopática e nas doenças inflamatórias intestinais, o crescimento é comprometido também pelo processo inflamatório. Muitas vezes, o tratamento da doença de base compromete o crescimento, especialmente quando é necessário glicocorticóides. Em algumas situações é possível comprovar a deficiência associada de hormônio de crescimento (GH, do inglês growth hormone). Em outras, os exames sugerem certo grau de insensibilidade ao GH. O tratamento destes pacientes com GH tem se mostrado útil e seguro com melhora do crescimento e da qualidade de vida. Nesta revisão, são apresentados resultados do tratamento com GH em pacientes com baixa estatura decorrente de doenças crônicas, algumas indicações já bem definidas e outras ainda em investigação.

Growth disorders are commonly observed in children suffering from chronic diseases. The pathogenesis of growth failure is multifactorial. In chronic inflammatory diseases such as juvenile idiopathic arthritis and inflammatory bowel disease, growth is also affected by pro-inflammatory cytokines. Patients with chronic diseases might also become growth hormone (GH) deficient. However, normal or increased GH secretion with reduced plasma concentrations of insulin-like growth factor-I indicate a degree of GH insensitivity in some patients. Growth damage can increase with specific treatments, especially if glucocorticoids are used. GH therapy has been used to reduce the consequences of the disease and long-term steroid therapy in these patients. In this review, it is reported the encouraging results of GH treatment in growth-retarded children with chronic diseases, both in well defined indications as well in situations still under investigation.

Deficiencia somatotrófica en niños: características clínicas y bioquímicas según la etiología en 75 casos / Somatotrophic deficiency in children: report of 75 cases

Somatotrophic deficiency (SDMT) can be due to a deficiency of growth hormone releasing hormone(GHRH), growth hormone (GH) or insulin like growth factor I (IGF-I). Although its clinical features have been thoroughly described, the diagnosis is still controversial. Now there is an effective treatment with GH or IGF-I for these patients. AIM: To analyze the main clinical, etiological and laboratory characteristics of 75 SD patients (44 males), aged 9.4 + 4.5 years, with severe growth retardation. The diagnosis was confirmed by the lack of response to two GH stimulation tests (Clonidine, Glugagon or Insulin) and low levels of IGF-I or insulin-like growth factor binding protein- 3 (IGFBP-3). RESULTS: In 34 patients (46 percent), the cause of DSMT was considered idiopathic (DSMT-I), in 31 (41 percent) there was an organic cause (DSMT-O), most commonly caused by malformations or pituitary tumors and in 10 (13 percent), it was genetic (DSMT-G) (three patients with Laron's Syndrome, five with mutations of GH gene and 2 with probable mutations of Prop-1 and Pit-1 genes). IGF-1 levels, were significantly lower in DSMT-O and DSMT-G thanin DSMT-I (21.2 +/- 46.1, 23.4 +/-30.3 ng/mL and 50.2 +/- 48.3 ng/mL, respectively). The lowest height score corresponded to DSMT-G, compared to DSMT-O and DSMT (­5.7 +/- 0.9, -4.0 +/- 1.6 and ­4.3 +/- 1.2 DS, respectively) CONCLUSIONS: The high percentage of organic and genetic etiologies in our patients can be due to the systematic search of these diseases. DSMT-G (Laron, mutations in GH and Pit-1 genes) had the most severe growth retardation.

[ causes of short stature among children in Gorgan-Iran]

Short stature among children is often due to physiological causes but it can be a sign of important and curable diseases. Thus early detection of problem, before epiphyseal closure, is critical. This study was done to determine the cause of short stature among children in Gorgan-Iran. This cross- sectional research study was done on 100 children of 6-14 years of age during 2005 in Gorgan-Iran. Children were selected by census. Demographic character of children, history of serious disease, prematurity, blood and provocative growth hormone tests, physical examination, wrist radiography and standard deviation score [SDS] were recorded for each child. Data were analyzed by t-student and chi-square tests. The finding of this study showd that most children with short stature was girl [66%]. mean+-SD of calendar and bone age of female children was 10.4+-2.25 and 8.4+-2.32 year, respectively. The most frequent causes of short stature were constitutional [57%], Growth hormone deficiency [30%] and familial causes [8%]. Mean+-SD of calendar and bone age of males children was 10.79+-2.32 and 7.89+-2.19 years. Children with growth hormone deficiency had lower bone age and children with constitutional short stature had higher standard deviation score than others. [P<0.05]. This study showed that since growth hormone deficiency was one of the common and important pathologic causes of short stature. Therefore growth hormone determination and theraphy is recommended, after elimination of familial and constitutional factors

Lower Limb Lengthening in Turner Dwarfism

The aim of this study was to review our cases of lower limb lengthening to treat Turner dwarfism, and to speculate whether or not effective limb lengthening can be achieved in this rare condition. Twelve tibiae and 2 femora were lengthened in 6 patients using the Ilizarov method for the tibia and a gradual elongation nail for the femur. The mean age at the time of surgery was 19 years, and the patients were followed up for a minimum of 2 years. The average gain in the tibial and femoral length was 6.2 cm and 6.0 cm, respectively. The average healing index of tibia and femur was 1.9 and 1.7 months. The average tibia-to-femur ratio improved from 0.68 preoperatively to 0.81 postoperatively, and leg-trunk ratios improved from 0.88 to 0.99. Seven segments (50.0 percent) had completed the lengthening protocol without complications. Two segments (14.3 percent) had an intractable pin site infection requiring a pin exchange, and four segments (35.7 percent) had twelve complications (a nonunion at the distraction site, premature consolidation, Achilles tendon contractures and planovalgus). The overall rate of complications was 100 percent for each bone lengthened. All the patients showing a nonunion at the distraction site had a reduced bone mass, which was less than 65 percent of those of the age-matched normal population. Despite the complications, all patients were satisfied with the results, and lower limb lengthening in Turner Dwarfism believed to be a valid option. However, it may require careful management in a specialist unit in order to prevent complications during the lengthening procedure. In addition, the osteopenia associated with an estrogen deficiency leading to problems in consolidation is a difficult issue to address.

Enanismo por desnutricion: cronodinamia de los procesos metabolicos en ratas / Nutrition dwarfing: longitudinal analysis of anthropometric and metabolic parameters in rats

El enanismo por desnutrición es una enfermedad no orgánica, cuya causa es la reducción voluntaria o no intencional de la ingesta de alimentos, debida a hábitos alimentarios inapropiados, insatisfacción en el peso corporal o a inadecuadas dietas para adelgazar. Los pacientes con retardo en el crecimiento debido a una causa nutricional logram alcanzar un crecimiento que es el equilibrio entre el potencial genético para el crecimiento y la ingesta de nutrientes. Esta desaceleración en el crecimiento produce una adaptación metabólica que no se refleja en los parámetros bioquímicos tradicionales utilizados como marcados de malnutrición. El objetivo de nuestro trabajo fue comparar en un modelo experimental en ratas en crecimineto las posibles modificaciones en la utilización de sustrato endógeno (CC), el consumo de oxígeno (VO2) y la velocidad de crecimiento. Se emplearon 30 ratas macho de la cepa Wistar que al momento del destete se subdividieron en 3 grupos: control (C) y experimentales: E4 y E8. El grupo C recibió una dieta stock ad libitum. El E4 y E8 recibieron por cada 100 gr de peso corporal un 80 por ciento de la misma dieta durante 4 y 8 semanas, respectivamente. Durante el período de depleción nutricional se midieron los siguientes parámetros: 1) peso (P) y talla (T) corporales en función de la edad, 2) P/T Z Score, 3) Composición corporal (CC) por el EM-SCAN, TOBEC modelo SA 3000/3076, Springfield, USA, 4) VO2 por calorimetría indirecta (ECO-OXYMAX, Columbus Instruments). Se obtuvieron los siguientes resultados a las 4 y 8 semanas, respectivamente: 1) La categoría antropométrica (CA) de delgado (P/T Z Score: -0.70 + 0.43) y de desnutrido (P/T Z Score: -1.44 + 0.32), respectivamente, 2) La reserva lipídica fluctuó dentro del rango normal con una cronodinamia significativamente diferente respecto de la del C. 3) No hubo diferencia significativa del VO2 entre C, E4 y E8. Los resultados obtenidos sugieren que la ingesta crónica de una cantidad subóptima (80 por ciento) de una dieta balanceada afecta el crecimiento corporal sin alterar el desarrollo del individuo.

Síndrome de Hallermann*Streiff*Francois: a propósito de 7 casos

En el servicio de Oftalmología del Complejo Hospitalario `Daniel Alcides Carrión' del Callao, entre los años 1981 y 1983 han sido estudiados 7 casos portadores del síndrome Hallerman-Streiff-Francois. Este síndrome está caracterizado por discefalia con cara de pájaro, anomalías dentales, nanismo proporcionado, hipotricosis, atrofia de piel, microftalmía y catarata congénita bilateral. De ellos, 2 casos asistieron espontáneamente al servicio, 4 proceden del Centro de Educación Especial ` San Francisco de Asís', 1 procedente del centro de Educación Especial `Santa Lucía'. Estos dos últimos centros educativos están dedicados a la enseñanza de niños con ceguera y visión subnormal. En todos ellos se ha practicado examen clínico general y estudio oftalmológico, prestando especial atención a los antecedentes personales y familiares